Back to IKT
UBS Group AG IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$1.3M
Q3 2026
Peak value
$1.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $221K |
| Q3 2025 | $168 |
| Q4 2025 | $187K |
| Q4 2025 | $7K |
| Q1 2026 | $362K |
| Q1 2026 | $21K |
| Q2 2026 | $415K |
| Q3 2026 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.3M | 621.6K | — | — |
| Q2 2026 | $415K | 204.7K | — | — |
| Q1 2026 | $21K | 12.5K | — | — |
| Q1 2026 | $362K | 215.7K | — | — |
| Q4 2025 | $7K | 3.5K | — | — |
| Q4 2025 | $187K | 91.1K | — | — |
| Q3 2025 | $168 | 104 | — | — |
| Q3 2025 | $221K | 136.2K | — | — |